Argent Advisors, Inc. Abbott Laboratories Transaction History

Argent Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 26, 2022	SELL	$114.02 - $139.04 $163,618 - $199,522	-1,435 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$115.53 - $141.46 $165,785 - $202,995	1,435 New	1,435 $202,000
Q1 2021 Apr 27, 2021	SELL	$108.84 - $128.23 $208,319 - $245,432	-1,914 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$105.0 - $114.42 $49,140 - $53,548	-468 Reduced 19.65%	1,914 $210,000
Q3 2020 Oct 29, 2020	SELL	$91.64 - $111.29 $2,474 - $3,004	-27 Reduced 1.12%	2,382 $259,000
Q2 2020 Aug 11, 2020	BUY	$76.57 - $98.0 $184,457 - $236,082	2,409 New	2,409 $220,000
Q1 2020 Apr 23, 2020	SELL	$62.82 - $91.86 $99,820 - $145,965	-1,589 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $124,752 - $138,878	1,589 New	1,589 $254,000

3,204

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $219B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Argent Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Argent Advisors, Inc. with notifications on news.